DE69310461T2 - Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung - Google Patents

Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung

Info

Publication number
DE69310461T2
DE69310461T2 DE69310461T DE69310461T DE69310461T2 DE 69310461 T2 DE69310461 T2 DE 69310461T2 DE 69310461 T DE69310461 T DE 69310461T DE 69310461 T DE69310461 T DE 69310461T DE 69310461 T2 DE69310461 T2 DE 69310461T2
Authority
DE
Germany
Prior art keywords
mixture
soft capsules
enteric coating
weight
triacetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69310461T
Other languages
English (en)
Other versions
DE69310461D1 (de
Inventor
Shrikant Narayan Pagay
Gregg Stetsko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE69310461D1 publication Critical patent/DE69310461D1/de
Publication of DE69310461T2 publication Critical patent/DE69310461T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE69310461T 1992-08-26 1993-08-21 Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung Expired - Lifetime DE69310461T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/935,505 US5330759A (en) 1992-08-26 1992-08-26 Enteric coated soft capsules and method of preparation thereof

Publications (2)

Publication Number Publication Date
DE69310461D1 DE69310461D1 (de) 1997-06-12
DE69310461T2 true DE69310461T2 (de) 1997-12-11

Family

ID=25467257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69310461T Expired - Lifetime DE69310461T2 (de) 1992-08-26 1993-08-21 Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung

Country Status (12)

Country Link
US (1) US5330759A (de)
EP (1) EP0587220B1 (de)
JP (1) JP3983823B2 (de)
AT (1) ATE152618T1 (de)
AU (1) AU672982B2 (de)
CA (1) CA2101095C (de)
DE (1) DE69310461T2 (de)
DK (1) DK0587220T3 (de)
ES (1) ES2104044T3 (de)
GR (1) GR3024351T3 (de)
HU (1) HUT64833A (de)
MX (1) MX9305108A (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
EE03305B1 (et) * 1994-07-08 2000-12-15 Astra Aktiebolag Paljuosaline tableteeritud annusvorm I
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
JP3625940B2 (ja) * 1996-01-29 2005-03-02 信越化学工業株式会社 水系液のカプセルおよびその製造方法
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
NZ529928A (en) 1999-10-29 2005-10-28 Euro Celtique Sa Controlled release hydrocodone formulations
KR101045144B1 (ko) 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
HUE031650T2 (en) 2002-10-01 2017-07-28 Banner Life Sciences Llc Enterosolvent preparation for soft capsule wall production
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
WO2006110807A1 (en) * 2005-04-12 2006-10-19 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
US20070148248A1 (en) 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
ES2463774T3 (es) 2007-11-12 2014-05-29 Pharmaceutics International, Inc. Complejos trimoleculares y su uso en sistemas de administración de fármacos
JP5074583B2 (ja) * 2008-05-08 2012-11-14 パナソニック株式会社 不揮発性記憶素子の製造方法、および不揮発性記憶装置の製造方法
KR101783945B1 (ko) * 2009-05-12 2017-10-10 비피에스아이 홀딩스, 엘엘씨. 향상된 수분차단 속방출형 필름의 코팅 시스템 및 이에 의하여 코팅된 기재
EP2429504A4 (de) * 2009-05-12 2013-05-01 Bpsi Holdings Llc Filmbeschichtungen mit entklebern in feinpartikelgrösse und damit beschichtete substrate
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
RU2014141201A (ru) 2012-03-29 2016-05-20 ТЕРАБАЙОМ, ЭлЭлСи Композиции для желудочно-кишечной сайт-специфической пероральной вакцинации, проявляющие активность в подвздошной кишке и аппендиксе
JP6464142B2 (ja) * 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
DK2946774T3 (da) * 2014-05-19 2020-05-25 Tillotts Pharma Ag Coatede kapsler med modificeret frigivelse
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
ES2929218T3 (es) * 2015-01-12 2022-11-28 Enteris Biopharma Inc Formas farmacéuticas orales sólidas
CN104825418B (zh) * 2015-05-07 2018-05-15 上海信谊万象药业股份有限公司 一种硝苯地平软胶丸及其制备方法
US9993426B2 (en) 2015-09-15 2018-06-12 C. B. Fleet Company, Inc. Bisacodyl compositions and delivery apparatus
CA3111272A1 (en) 2018-09-05 2020-03-12 Renapharma AB An iron containing composition and use thereof
JP2022531685A (ja) 2019-05-07 2022-07-08 バウシュ ヘルス アイルランド リミテッド メチルナルトレキソンの液体経口投与製剤
WO2021224138A1 (en) 2020-05-02 2021-11-11 Bausch Health Ireland Limited Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone
EP4169503A1 (de) 2021-10-20 2023-04-26 Tessenderlo Group NV Zusammensetzung mit gelatine, gelatinefilme und kapseln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234331C2 (de) * 1982-09-16 1986-06-05 A. Nattermann & Cie GmbH, 5000 Köln Verfahren und Lösungen zum Beschichten von Gelatinekapseln mit magensaftresistenten Überzügen
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
EP0313845A1 (de) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilisierung von enterischen beschichteten Dosierungsformen
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
NL9002336A (nl) * 1990-10-24 1992-05-18 Leuven K U Res & Dev Bekledings- of matrixmateriaal voor geneesmiddelen.

Also Published As

Publication number Publication date
JPH06157295A (ja) 1994-06-03
MX9305108A (es) 1994-02-28
AU672982B2 (en) 1996-10-24
HU9302426D0 (en) 1993-11-29
GR3024351T3 (en) 1997-11-28
EP0587220A1 (de) 1994-03-16
EP0587220B1 (de) 1997-05-07
US5330759A (en) 1994-07-19
AU4488893A (en) 1994-03-03
ATE152618T1 (de) 1997-05-15
ES2104044T3 (es) 1997-10-01
JP3983823B2 (ja) 2007-09-26
DE69310461D1 (de) 1997-06-12
HUT64833A (en) 1994-03-28
DK0587220T3 (da) 1997-12-01
CA2101095A1 (en) 1994-02-27
CA2101095C (en) 2004-01-20

Similar Documents

Publication Publication Date Title
DE69310461T2 (de) Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung
US5112621A (en) Sustained release pharmaceutical composition of diltiazem
JP4381479B2 (ja) ジルチアゼム除放性製剤
US5364620A (en) Controlled absorption diltiazem formulation for once daily administration
RU2004121786A (ru) Лекарственные составы длительного высвобождения, содержащие в качестве активного соединения венлафаксина гидрохлорид
PL323362A1 (en) Method of treating inflammatory inteestine diseases using oral preparations of polyunsaturated omega-3 acids
JPS57171428A (en) Preparation of coated solid preparation
KR910011243A (ko) 서방성 약제 용량 단위
NO175618C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med kontrollert frigjöring for oral administrering omfattende atskilte enheter omfattende acrivastin eller et salt derav
US5219621A (en) Methods of treatment with diltiazem formulations
RU2011101918A (ru) Получение лекарственных форм миорелаксантов скелетных мышц с контролируемым высвобождением
KR970001656B1 (ko) 조절흡수 딜티아젬 제제
FI821422A0 (fi) Foerfarande foer framstaellning av ett nytt farmaceutiskt preparat
US5336504A (en) Diltiazem formulations and methods of treatment
CA2466726A1 (en) Preparation composition containing acid-unstable physiologically active compound and process for producing same
DE69102415D1 (de) Ester der 10-(1-Hydroxy-äthyl)-11-oxo-1-Azatricyclo[7.2.0.0(3,8)]undec-2-ene-2-Carbonsäure und deren Derivate und Verfahren zu ihrer Herstellung.
JPH01131116A (ja) １，４−ジヒドロピリジン化合物の腸溶性製剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8328 Change in the person/name/address of the agent

Free format text: MUELLER, SCHUPFNER & GAUGER, 80539 MUENCHEN